A recent review in JAMA reveals that low-dose corticosteroids may reduce mortality in critically ill adults with severe pulmonary infections, including COVID-19, community-acquired bacterial pneumonia, and Pneumocystis pneumonia.
The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
Analysis of post-COVID-19 pediatric respiratory syncytial virus cases shows increased hospitalizations and respiratory support needs, with changes in patient age and comorbidities.
A systematic review and meta-analysis reveals that traditional mind-body exercises improve lung function, exercise capacity, and quality of life in patients with COPD.
A study published in JAMA Internal Medicine revealed that nicotine-containing e-cigarettes and varenicline significantly outperformed placebo in helping over 40% of participants achieve smoking abstinence at 6 months.